NDC 65862-842

Entecavir

Entecavir

Entecavir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Entecavir.

Product ID65862-842_291c128c-ff8e-4041-a8e7-050124d6076b
NDC65862-842
Product TypeHuman Prescription Drug
Proprietary NameEntecavir
Generic NameEntecavir
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-08-26
Marketing CategoryANDA / ANDA
Application NumberANDA206217
Labeler NameAurobindo Pharma Limited
Substance NameENTECAVIR
Active Ingredient Strength1 mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65862-842-30

1 BOTTLE in 1 CARTON (65862-842-30) > 30 TABLET in 1 BOTTLE
Marketing Start Date2015-08-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65862-842-30 [65862084230]

Entecavir TABLET
Marketing CategoryANDA
Application NumberANDA206217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-08-26

NDC 65862-842-99 [65862084299]

Entecavir TABLET
Marketing CategoryANDA
Application NumberANDA206217
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-26

NDC 65862-842-90 [65862084290]

Entecavir TABLET
Marketing CategoryANDA
Application NumberANDA206217
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-26

Drug Details

Active Ingredients

IngredientStrength
ENTECAVIR1 mg/1

OpenFDA Data

SPL SET ID:def332bf-2906-4a6c-b85d-dfb56bb94312
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 485434
  • 485436
  • UPC Code
  • 0365862841308
  • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    Medicade Reported Pricing

    65862084230 ENTECAVIR 1 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Entecavir" or generic name "Entecavir"

    NDCBrand NameGeneric Name
    0093-5786EntecavirEntecavir
    0093-5787EntecavirEntecavir
    10135-615EntecavirEntecavir
    10135-616EntecavirEntecavir
    16714-717ENTECAVIRENTECAVIR
    16714-718ENTECAVIRENTECAVIR
    16729-388EntecavirEntecavir
    16729-389EntecavirEntecavir
    31722-833EntecavirEntecavir
    31722-834EntecavirEntecavir
    42291-261EntecavirEntecavir
    42291-262EntecavirEntecavir
    68382-920EntecavirEntecavir
    68382-921EntecavirEntecavir
    69097-425ENTECAVIRENTECAVIR
    69097-426ENTECAVIRENTECAVIR
    70771-1019EntecavirEntecavir
    70771-1020EntecavirEntecavir
    43547-437ENTECAVIRENTECAVIR
    43547-436ENTECAVIRENTECAVIR
    49884-547EntecavirEntecavir
    49884-548EntecavirEntecavir
    51407-065EntecavirEntecavir
    51407-064EntecavirEntecavir
    52343-147ENTECAVIRENTECAVIR
    51991-896EntecavirEntecavir
    51991-895EntecavirEntecavir
    52343-148ENTECAVIRENTECAVIR
    60687-216EntecavirEntecavir
    65162-446EntecavirEntecavir
    65862-842EntecavirEntecavir
    65162-449EntecavirEntecavir
    65862-841EntecavirEntecavir
    62227-102EntecavirEntecavir
    62227-101EntecavirEntecavir
    0003-1611BARACLUDEentecavir
    0003-1612BARACLUDEentecavir
    0003-1614BARACLUDEentecavir

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.